The tariff classification of a locking medicine container from China.
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Ruling text
In your letter dated July 30, 2025, you requested a tariff classification ruling on behalf of your client, Safe RX. A sample was provided and will be retained as requested. The product under consideration is described as the “Safe Rx® Locking Prescription Vial (LPV®).” It is a plastic medicine container that features a lid with a four-digit locking mechanism that allows this item to function as a secure medication storage device.
From review of the sample, we note that the lock does not feature any metal components. This item has the general appearance of a standard prescription medicine bottle except with the modified locking lid.
In your submission, you requested consideration of a secondary classification for this item under subheading 9817.00.96, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “[a]rticles specially designed or adapted for the use or benefit of the blind or other physically or mentally handicapped persons; parts and accessories (except parts and accessories of braces and artificial limb prosthetics) that are specially designed or adapted for use in the foregoing articles: [o]ther.” We disagree with this proposed classification.
While your submission primarily focuses on this being used in the treatment of individuals suffering from Opioid Use Disorder, we confirmed that it has broader utility on your client’s website, https://safe-rx.com/.
Their site states that these locking prescription vials “are used broadly to prevent diversion and accidental pediatric ingestion, for means reduction in suicide prevention, to reduce patient barriers to MAT enrollment, and even to ensure the integrity of home delivery chains of custody.” Additionally, they “provide portable and private storage of high cost or sensitive medications whether you’re at home, traveling or coworkers.
With an opaque bottle and locked cap, no one can see your medication, keeping your healthcare private.” Finally, these containers “provide peace of mind for families. Whether you are worried about teenagers and their friends, neighbors, household visitors or tradesmen, our product is an effective and easy-to-use solution.
With its combination lock and tamper-resistant design, our LPVs provide an extra layer of security, giving you the confidence and assurance that your family is safe.” From this additionally obtained information, we hold the opinion that this product is not “specifically designed or adapted” for the handicapped and that it is general enough in nature that it lacks the characteristics “that create a substantial probability of use by the chronically handicapped” and is not “easily distinguishable from articles useful to the general public,” to the extent that the “use thereof by the general public is so improbable that it would be fugitive.” See Implementation of the Nairobi Protocol, 26 Cust.
Bull. & Dec. at 243-244. Therefore, we find that the secondary classification of 9817.00.96, HTSUS, would not apply to this locking medicine container.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N351822).